Skip to main content
OpenTrials
Completed

NCT Number: NCT00335049

Study of Theories About Myopia Progression (STAMP)

At this time, we do not know what causes a child to become more nearsighted (myopic). STAMP will help us better understand nearsightedness in children. Children will be randomly chosen to wear regular glasses (single vision lenses) or no-line bifocal glasses (progressive addition lenses) for the first year of the study. All children will wear regular glasses for the second year of the study. STAMP will compare how the eye changes shape in the two groups to help us understand why children become nearsighted. The two theories of myopia progression that are being evaluated are based on different factors. One theory is based on environmental factors such as extended near work while the other theory is based on genetically coded factors.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 year–11 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Ohio State University College of Optometry

Columbus, Ohio, 43210, United States

About this study

Eligible children will be enrolled, randomized, and followed at six-month intervals for two years with all children wearing single vision lenses for the second year. At each visit, complete measurements of the components of the eye will be made to explain the mechanism responsible for the Progressive Addition Lens (PAL) treatment effect and why it occurs mainly during the first year of bifocal wear (Gwiazda et al. 2003). While hyperopic retinal blur (blur at the back of the eye) due to accommodative lag (poor focusing when doing close work) has been proposed as a possible mechanism driving myopia progression (Gwiazda et al. 1993), others have shown that accommodative lag accompanies rather than precedes the onset of myopia (Mutti et al., 2006). This suggests that accommodative lag is a result of another possible mechanism resulting in myopia progression such as crystalline lens-induced ciliary-choroidal tension (a model in which the lens in the eye is stretched and is not as good at focusing up close) (Mutti et al., 2000). According to this proposed mechanism, high accommodative lag in myopia results from increased crystalline lens tension that is transmitted through the choroid (an outside layer of the eye). This tension results in restricted equatorial (the vertical dimension of the eye) eye growth with no axial (front to back) restriction to eye growth and yields a prolate ocular shape (an eye that is longer than it is wide) in myopes (Mutti et al., 2000).

Comparisons: Refractive error (glasses prescription), axial length (length of the eye), peripheral eye shape, accommodation (focusing ability), corneal shape (shape of the front of the eye), anterior chamber depth, crystalline lens thickness and curvatures (shape of the lens in the eye), central and peripheral higher-order aberrations (how well light focuses in the eye), and phoria (eye alignment) will be measured at six-month intervals. The primary study outcome is refractive error measured by cycloplegic autorefraction. Comparison of the biometric data collected both during the first year when the PAL intervention is present and during the second year when the PAL intervention is removed will allow us to differentiate between the two theories under consideration. We will also evaluate whether the modest PAL treatment effect that has been reported during the first year of PAL wear is permanent.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 6 to 11 years of age
  • Best corrected vision of at least 20/30 in each eye
  • Birth weight > 1250g

(The criteria below will be evaluated at a screening visit to find out if the child can participate)

  • Accommodative lag >= 1.30 D (for a 4D stimulus)
  • At least -0.75 D myopia in each meridian measured with cycloplegic autorefraction but not more than -4.50 D in each meridian in each eye
  • Esophoria at near if more than -2.25 D spherical equivalent (high myopia)
  • Astigmatism < 2.00 DC in each eye
  • Anisometropia < 2.00 D

Exclusion criteria

  • Strabismus (eye turn)
  • History of contact lens wear
  • History of previous bifocal wear
  • Diabetes mellitus

Treatment and study plan

progressive addition spectacle lens (bifocal)

Device

Progressive addition lenses (PAL) with a +2.00 D add.

Other names: PAL

Single Vision Lenses (SVLs)

Device

Single vision spectacle lenses.

Other names: SVL

Primary outcomes

  1. Cycloplegic autorefraction

    Time frame: Baseline, 6, 12, 18, and 24 months

Secondary outcomes

  1. Phoria

    Time frame: Baseline, 6, 12, 18, and 24 months

  2. Accommodative lag

    Time frame: Baseline, 6, 12, 18, and 24 months

  3. AC/A ratio

    Time frame: Baseline, 6, 12, 18, and 24 months

  4. Corneal shape and thickness

    Time frame: Baseline, 6, 12, 18, and 24 months

  5. Intraocular pressure

    Time frame: Baseline, 6, 12, 18, and 24 months

  6. Peripheral ocular shape

    Time frame: Baseline, 6, 12, 18, and 24 months

  7. Central and peripheral aberrations

    Time frame: Baseline, 6, 12, 18, and 24 months

  8. Crystalline lens thickness and curvature

    Time frame: Baseline, 6, 12, 18, and 24 months

  9. Anterior chamber depth

    Time frame: Baseline, 6, 12, 18, and 24 months

  10. Axial length

    Time frame: Baseline, 6, 12, 18, and 24 months

Sponsors and collaborators

Lead sponsor

Ohio State University

Other

Collaborators

  • National Eye Institute (NEI)

Registry information

Important dates

Study start
2006
Primary completion
2010
Study completion
2010
First posted
Jun 8, 2006
Registry last updated
Oct 28, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.